Jeffrey Silbiger, MD
Cardiovascular Disease · Elmhurst, NYNPI 1013921782
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $16,600 of the $17,606 with a category attached, or 94.3%. Lantheus Medical Imaging, Inc. accounts for 96.7% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2022 at $9,571 and has fallen 99.2% since, to $79 in 2025. Among cardiovascular disease clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 48 payments — averaging $366.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lantheus Medical Imaging, Inc.$17K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$131
- Irhythm Technologies, Inc.$83
- Edwards Lifesciences$74
- Novartis$68
- Johnson & Johnson$67
- plus $162 from 4 others
What the payments were for
- Speaking & faculty fees$16,60094%
- Travel & lodging$1151%
- Food & beverage$8065%
- Education$850%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lantheus Medical Imaging, Inc. | 27 | $17,020 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $131 |
| Irhythm Technologies, Inc. | 1 | $83 |
| Edwards Lifesciences | 2 | $74 |
| Novartis | 3 | $68 |
| Johnson & Johnson | 2 | $67 |
| Abbott | 2 | $54 |
| Pfizer | 2 | $41 |
| Merck | 2 | $38 |
| E.r. Squibb & Sons, L.L.C. | 2 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Definity$16,715
How this compares
$17,606 in reported general payments places this provider in the 90th percentile of 2,302 cardiovascular disease providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Elmhurst
- Roger HajjarNew York$5.2M
- Szilard VorosStony Brook$3.7M
- Gregg StoneNew York$2M
- Augustin DelagoAlbany$1.8M
- Philippe GenereuxNew York$1.3M
- Adam RosenbluthNew York$1.1M
- Luigi di BiaseBronx$978K
- Vijay IyerAmherst$855K
- Megha PrasadNew York$813K
- Ronald DagostinoLake Success$782K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.